Financials data is unavailable for this security.
View more
Year on year Bayer Cropscience Ltd had little change in net income (from 7.58bn to 7.41bn). Revenues were also little changed (from 51.40bn to 51.03bn.)
| Gross margin | 39.76% |
|---|---|
| Net profit margin | 11.33% |
| Operating margin | 12.82% |
| Return on assets | 11.06% |
|---|---|
| Return on equity | 18.66% |
| Return on investment | 17.90% |
More ▼
Cash flow in INRView more
In 2024, Bayer Cropscience Ltd increased its cash reserves by 34.35%, or 2.96bn. The company earned 9.52bn from its operations for a Cash Flow Margin of 18.65%. In addition the company generated 4.00m cash from investing, though they paid out 6.56bn more in financing than they received.
| Cash flow per share | 143.68 |
|---|---|
| Price/Cash flow per share | 39.44 |
| Book value per share | 685.82 |
|---|---|
| Tangible book value per share | 656.42 |
More ▼
Balance sheet in INRView more
| Current ratio | 2.22 |
|---|---|
| Quick ratio | 1.57 |
| Total debt/total equity | 0.0108 |
|---|---|
| Total debt/total capital | 0.0107 |
More ▼
Growth rates in INR
Year on year, growth in dividends per share increased 7.69% while earnings per share excluding extraordinary items fell by -2.33%. The positive trend in dividend payments is noteworthy since only some companies in the Chemical Manufacturing industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
| Div yield(5 year avg) | 1.88% |
|---|---|
| Div growth rate (5 year) | 50.72% |
| Payout ratio (TTM) | 96.92% |
| EPS growth(5 years) | 10.91 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -31.36 |
More ▼
